MARKET

KHTRF

KHTRF

Knight Therapeut
OTCPK
6.70
NaN%
Closed 09:30 08/14 EDT
OPEN
--
PREV CLOSE
6.85
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
7.40
52 WEEK LOW
4.220
MARKET CAP
658.15M
P/E (TTM)
162.23
1D
5D
1M
3M
1Y
5Y
1D
Analyst Reiterates Buy on Knight Therapeutics, Citing Strong Q2 Beat, Raised Guidance and DCF-Supported C$12 Target Price
TipRanks · 5d ago
Knight Therapeutics price target raised to C$11 from C$9.50 at Stifel
TipRanks · 08/07 15:55
Knight Therapeutics price target raised to C$11 from C$9.50 at RBC Capital
TipRanks · 08/07 15:31
RBC Capital Remains a Buy on Knight Therapeutics (KHTRF)
TipRanks · 08/07 11:27
Knight Therapeutics reports Q2 results
Seeking Alpha · 08/06 18:03
Knight Therapeutics Announces Repayment of Revolving Credit Facility
Barchart · 06/17 16:30
Knight Announces Early Warning Filing Regarding Shares of Crescita
Barchart · 06/05 17:00
Knight to Present at the Jefferies 2026 Healthcare Conference in New York City
Barchart · 05/28 06:30
More
About KHTRF
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company monitors investments in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by the Company such as Exelon and Impavido.

Webull offers Knight Therapeutics Inc stock information, including OTCPK: KHTRF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KHTRF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KHTRF stock methods without spending real money on the virtual paper trading platform.